| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |